HNRNPA2B1 and breast carcinoma: To investigate whether HNRNPA2B1 induced endocrine resistance in breast cancer cells, researchers constructed HNRNPA2B1‐overexpressed MCF‐7 cells (formerly tamoxifen sensitive).